Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

PLX — Protalix BioTherapeutics, Inc.

EXPENSIVE (MOS Model unreliable) · Quality 87/100

Value Score 30 days ago: 18.4 → today 9.9

PLX - Protalix BioTherapeutics, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 3.13 USD
Intrinsic value: 0.7 USD
Margin of safety: Model unreliable
Implied growth (reverse DCF): +35.2% (model assumes +10.0%)
Valuation: EXPENSIVE
Value Score: 9.9
Quality: 87/100
Moat score: 26.2 (erosion: none)
EXPENSIVE (MOS Model unreliable) - Quality 87/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/PLX
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

3.13

Intrinsic value

0.7

Margin of safety

Model unreliable

Implied growth (reverse DCF)

+35.2%

model assumes +10.0%

Value Score

9.9

Quality

Psychology

-50.4

Discovery

price/volume attention only

Moat score

26.2

erosion: none

Value Score: bottom 46% of Russell 3000 · Quality: top 2%

Open the interactive Deep Dive for PLX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/PLX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is PLX undervalued?

As of 2026-11-11, PLX trades at 3.13 against a computed intrinsic value of 0.7 (-347.1% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Protalix BioTherapeutics, Inc.'s Value Score?

Protalix BioTherapeutics, Inc.'s Value Score is 9.9 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.